Lannett Co., Inc. (New York Stock Exchange:LCI)

About the company

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Philadelphia, PA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

1020

CEO

Timothy C. Crew

Exchange

New York Stock Exchange

Website

http://www.lannett.com

$542.00M

Total Revenue

1K

Employees

$242.82M

Market Capitalization

-7.99

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$175M

Operating Margin (in %)

Total operating margin

$59M

Net Margin (in %)

Total net margin

$-31M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 383533.80 82729.00 6.16 22.35 20.75
Merck & Co., Inc. MRK 199942.72 48081.00 7.51 19.73 21.10
Pfizer Inc. PFE 190383.75 50660.00 2.88 12.05 31.17
Eli Lilly & Co. LLY 155261.34 23087.00 52.69 27.37 23.97
AbbVie, Inc. ABBV 144918.98 34057.00 -23.20 17.28 24.65
Bristol Myers Squibb Co. BMY 111198.52 31006.00 2.70 94.54 3.08
Repligen Corp. RGEN 6389.28 286.00 6.13 278.40 8.11
Reata Pharmaceuticals, Inc. RETA 4824.84 20.00 22.85 -15.52 -150.30
Nektar Therapeutics NKTR 4363.04 137.00 3.41 -9.50 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 4053.40 1.00 37.48 -6.20 None
Allakos, Inc. ALLK 3236.42 None 7.03 -34.60 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2484.72 891.00 1.77 -8.50 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.72 None 6.80 -18.91 None
IGM Biosciences, Inc. IGMS 2237.27 None 9.86 -41.24 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1784.50 None 5.80 -28.62 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1578.64 30.00 5.62 -22.46 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1544.38 None 9.46 -16.76 None
Akcea Therapeutics, Inc. AKCA 1347.82 341.00 2.77 -47.91 -8.59
Tricida, Inc. TCDA 1319.57 None 6.78 -6.25 None
Kiniksa Pharmaceuticals Ltd. KNSA 1279.85 None 6.63 -10.58 None
Arcutis Biotherapeutics, Inc. ARQT 1154.40 None 4.92 -18.46 None
Akero Therapeutics, Inc. AKRO 1135.64 None 9.48 -22.38 None
Odonate Therapeutics, Inc. ODT 1127.52 None 9.24 -10.02 None
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Athenex, Inc. ATNX 1014.78 123.00 6.22 -9.43 -87.86
Constellation Pharmaceuticals, Inc. CNST 983.36 None 4.63 -10.60 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Gossamer Bio, Inc. GOSS 809.47 None 3.28 -4.07 None
Phathom Pharmaceuticals, Inc. PHAT 794.00 None 4.40 -2.92 None
Quanterix Corp. QTRX 732.51 60.00 6.46 -16.75 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Applied Therapeutics, Inc. APLT 711.70 14.00 4.60 -14.44 -19.41
Aprea Therapeutics, Inc. APRE 689.64 None 6.10 -20.40 None
Oric Pharmaceuticals, Inc. ORIC 687.96 None -7.47 -22.75 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Arcturus Therapeutics Holdings, Inc. ARCT 665.08 19.00 61.64 -23.91 -151.34
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 617.87 1679.00 4.25 -2.84 -11.85
Keros Therapeutics, Inc. KROS 612.72 8.00 -27.67 -28.85 -285.35
Oyster Point Pharma, Inc. OYST 548.10 None 5.51 -9.53 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Fulcrum Therapeutics, Inc. FULC 476.10 1.00 8.02 -6.90 None
Biospecifics Technologies Corp. BSTC 462.28 40.00 3.75 19.77 61.80
SIGA Technologies, Inc. SIGA 460.84 19.00 5.16 -23.42 -94.00
89bio, Inc. ETNB 457.80 None 5.65 -7.09 None
Satsuma Pharmaceuticals, Inc. STSA 441.32 None 4.34 -12.13 None
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
DURECT Corp. DRRX 395.25 28.00 30.36 -16.35 -82.94
Relmada Therapeutics, Inc. RLMD 394.02 0.00 5.88 -32.92 -877.66
Kala Pharmaceuticals, Inc. KALA 383.04 6.00 4.19 -4.17 None
Crinetics Pharmaceuticals, Inc. CRNX 382.56 1.00 4.83 -6.56 -447.78
TCR2 Therapeutics, Inc. TCRR 368.64 None 2.52 -36.57 None
Ocular Therapeutix, Inc. OCUL 357.12 6.00 -43.76 -3.90 None
Ovid Therapeutics, Inc. OVID 344.25 None 8.14 -5.28 None
Osmotica Pharmaceuticals Plc OSMT 343.44 232.00 2.61 -1.25 -115.44
Aeglea Biotherapeutics, Inc. AGLE 303.27 4.00 9.57 -3.78 -523.27
Urovant Sciences Ltd. UROV 295.80 None -5.24 -2.05 None
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Spero Therapeutics, Inc. SPRO 268.28 12.00 3.53 -3.30 -656.72
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
HOOKIPA Pharma, Inc. HOOK 267.80 13.00 2.42 -5.92 -333.02
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Lannett Co., Inc. LCI 242.82 542.00 0.83 -7.99 -5.77
Gritstone Oncology, Inc. GRTS 226.44 4.00 2.03 -2.17 None
KalVista Pharmaceuticals, Inc. KALV 211.68 12.00 2.34 -6.53 -263.38
Kaleido Biosciences, Inc. KLDO 207.90 None 7.37 -2.84 None
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Sutro Biopharma, Inc. STRO 194.81 41.00 3.70 -3.20 -148.06
Protara Therapeutics, Inc. TARA 191.34 None 2.88 -12.41 None
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 175.03 1.00 5.28 -4.11 None
Liquidia Technologies, Inc. LQDA 166.10 8.00 13.02 -3.37 -602.17
scPharmaceuticals, Inc. SCPH 156.37 119.00 4.00 -4.99 -27.05
Avenue Therapeutics, Inc. ATXI 156.00 532.00 28.68 -10.71 26.69
Cyclerion Therapeutics, Inc. CYCN 153.49 6.00 1.93 -1.48 None
Corvus Pharmaceuticals, Inc. CRVS 147.45 None 2.36 -3.12 None
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Lyra Therapeutics, Inc. LYRA 144.84 1.00 -1.23 -8.68 -491.16
Evelo Biosciences, Inc. EVLO 144.00 None 5.29 -1.64 None
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 125.60 None 2.93 -2.55 None
TFF Pharmaceuticals, Inc. TFFP 117.80 None 4.56 -3.04 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
NeuBase Therapeutics, Inc. NBSE 117.04 None 49.18 -2.62 None
Ayala Pharmaceuticals, Inc. AYLA 115.41 3.00 -2.72 -5.59 -679.19
Evolus, Inc. EOLS 100.50 45.00 1.80 -0.99 -217.51
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Eton Pharmaceuticals, Inc. ETON 94.32 1.00 10.27 -4.72 None
Milestone Pharmaceuticals, Inc. MIST 93.86 None 0.93 -1.51 None
EyePoint Pharmaceuticals, Inc. EYPT 78.49 26.00 5.54 -1.60 -196.30
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Clearside Biomedical, Inc. CLSD 76.67 6.00 9.84 -4.35 -293.61
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Baudax Bio, Inc. BXRX 65.70 None -1.79 -0.94 None
Navidea Biopharmaceuticals, Inc. NAVB 64.60 1.00 -47.50 -5.85 -65.13
BiomX, Inc. PHGE 60.06 None 1.58 -1.40 None
Genprex, Inc. GNPX 59.60 None 5.06 -4.36 None
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aridis Pharmaceuticals, Inc. ARDS 55.44 1.00 -22.81 -1.90 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 53.71 20.00 1.62 -2.85 -51.58
Menlo Therapeutics, Inc. MNLO 49.30 2.00 4.15 -0.53 -483.51
Edesa Biotech, Inc. EDSA 45.36 0.00 6.46 -0.48 -395.23
Eyenovia, Inc. EYEN 44.20 None 4.46 -2.16 None
Annovis Bio, Inc. ANVS 42.49 None 3.89 -33.72 None
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Citius Pharmaceuticals, Inc. CTXR 35.37 None 2.62 -2.05 None
AgeX Therapeutics, Inc. AGE 33.82 2.00 -44.50 -2.78 -658.11
Allena Pharmaceuticals, Inc. ALNA 33.81 None 4.45 -0.78 None
Mannatech, Inc. MTEX 33.70 156.00 1.42 7.59 3.45
Oncternal Therapeutics, Inc. ONCT 33.67 3.00 4.32 -1.34 -225.89
Acer Therapeutics, Inc. ACER 32.20 3.00 2.35 -1.23 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Aileron Therapeutics, Inc. ALRN 30.80 None 4.23 -1.16 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Millendo Therapeutics, Inc. MLND 25.20 0.00 0.59 -0.54 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.77 0.00 0.94 -0.95 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Adial Pharmaceuticals, Inc. ADIL 15.00 None 3.66 -1.97 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.33 5.00 -3.29 -0.45 -602.34
PDS Biotechnology Corp. PDSB 13.30 None 1.47 -0.52 None
Titan Pharmaceuticals, Inc. TTNP 12.07 4.00 5.03 -0.67 -437.91
Novus Therapeutics, Inc. NVUS 7.44 None 0.64 -0.35 None
Brickell Biotech, Inc. BBI 4.68 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Is Lannett Company, Inc. (LCI) A Good Stock To Buy?

17d ago, source: YAHOO!

In this article, we look at what those funds think of Lannett Company, Inc. (NYSE:LCI) based on that data. Is Lannett Company, Inc. (NYSE:LCI) the right investment to pursue these days?

Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting

28d ago, source: YAHOO!

Company Anticipates Biosimilar Application to be Submitted By End of Calendar Year 2022-- PHILADELPHIA, June 11, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today said that ...

Seymour resident starts online coffee company

2d ago, source: Seymour Tribune

After a Seymour man went shopping for coffee at the grocery store one day, he had an epiphany.Logan Mead wanted to try ...

SpaceGuard Products celebrates 30 years in Seymour

7d ago, source: Seymour Tribune

SpaceGuard Products President Eddie Murphy hinted at some changes and growth on the horizon. A 29,000-square-foot addition ...

Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting

28d ago, source: Daily Local News

Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the ...

Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting

28d ago, source: PR Newswire

PHILADELPHIA, June 11, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today said that representatives from the company spoke with and received guidance from the U.S. Food and Drug ...

Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting

28d ago, source: MarketWatch

(NYSE: LCI) today said that representatives from the company spoke with and received guidance from the U.S. Food and Drug Administration (FDA) on the clinical advancement program of its biosimilar ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.